BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 23441229)

  • 1. CD8 T cell memory recall is enhanced by novel direct interactions with CD4 T cells enabled by MHC class II transferred from APCs.
    Romagnoli PA; Premenko-Lanier MF; Loria GD; Altman JD
    PLoS One; 2013; 8(2):e56999. PubMed ID: 23441229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presentation of acquired peptide-MHC class II ligands by CD4+ regulatory T cells or helper cells differentially regulates antigen-specific CD4+ T cell response.
    Zhou G; Ding ZC; Fu J; Levitsky HI
    J Immunol; 2011 Feb; 186(4):2148-55. PubMed ID: 21242518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-specific CD4+ T cells are activated by "cross-dressed" dendritic cells presenting peptide-MHC class II complexes acquired from cell-based cancer vaccines.
    Dolan BP; Gibbs KD; Ostrand-Rosenberg S
    J Immunol; 2006 Feb; 176(3):1447-55. PubMed ID: 16424172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4+ Th-APC with acquired peptide/MHC class I and II complexes stimulate type 1 helper CD4+ and central memory CD8+ T cell responses.
    Umeshappa CS; Huang H; Xie Y; Wei Y; Mulligan SJ; Deng Y; Xiang J
    J Immunol; 2009 Jan; 182(1):193-206. PubMed ID: 19109150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential kinetics of antigen dependency of CD4+ and CD8+ T cells.
    Rabenstein H; Behrendt AC; Ellwart JW; Naumann R; Horsch M; Beckers J; Obst R
    J Immunol; 2014 Apr; 192(8):3507-17. PubMed ID: 24639353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct CD4 help provision following interaction of memory CD4 and CD8 T cells with distinct antigen-presenting dendritic cells.
    de Goër de Herve MG; Dembele B; Vallée M; Herr F; Cariou A; Taoufik Y
    J Immunol; 2010 Jul; 185(2):1028-36. PubMed ID: 20562265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple paths for activation of naive CD8+ T cells: CD4-independent help.
    Wang B; Norbury CC; Greenwood R; Bennink JR; Yewdell JW; Frelinger JA
    J Immunol; 2001 Aug; 167(3):1283-9. PubMed ID: 11466344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stroma-dependent development of two dendritic-like cell types with distinct antigen presenting capability.
    Periasamy P; O'Neill HC
    Exp Hematol; 2013 Mar; 41(3):281-92. PubMed ID: 23178375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of memory CD4 T cell activation: MHC class II molecules on APCs and CD4 ligation inhibit memory but not naive CD4 T cells.
    Farber DL; Luqman M; Acuto O; Bottomly K
    Immunity; 1995 Mar; 2(3):249-59. PubMed ID: 7535181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human CD4+ T cells displaying viral epitopes elicit a functional virus-specific memory CD8+ T cell response.
    Adamopoulou E; Diekmann J; Tolosa E; Kuntz G; Einsele H; Rammensee HG; Topp MS
    J Immunol; 2007 May; 178(9):5465-72. PubMed ID: 17442927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide-specific intercellular transfer of MHC class II to CD4+ T cells directly from the immunological synapse upon cellular dissociation.
    Wetzel SA; McKeithan TW; Parker DC
    J Immunol; 2005 Jan; 174(1):80-9. PubMed ID: 15611230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen-presenting T cells induce the development of cytotoxic CD4+ T cells. I. Involvement of the CD80-CD28 adhesion molecules.
    Mauri D; Wyss-Coray T; Gallati H; Pichler WJ
    J Immunol; 1995 Jul; 155(1):118-27. PubMed ID: 7541409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host MHC class II+ antigen-presenting cells and CD4 cells are required for CD8-mediated graft-versus-leukemia responses following delayed donor leukocyte infusions.
    Chakraverty R; Eom HS; Sachs J; Buchli J; Cotter P; Hsu R; Zhao G; Sykes M
    Blood; 2006 Sep; 108(6):2106-13. PubMed ID: 16757687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-dressed dendritic cells drive memory CD8+ T-cell activation after viral infection.
    Wakim LM; Bevan MJ
    Nature; 2011 Mar; 471(7340):629-32. PubMed ID: 21455179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigen presentation by mouse CD4+ T cells involving acquired MHC class II:peptide complexes: another mechanism to limit clonal expansion?
    Tsang JY; Chai JG; Lechler R
    Blood; 2003 Apr; 101(7):2704-10. PubMed ID: 12433692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.
    Schirrmacher V; Schild HJ; Gückel B; von Hoegen P
    Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():311-26. PubMed ID: 7901150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic interactions of CD4+ and CD8+ T cell subsets with human vascular endothelial cells in primary proliferative allogeneic responses.
    Brooks CJ; Stackpoole A; Savage CO
    Int Immunol; 1993 Sep; 5(9):1041-8. PubMed ID: 7902126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of antigen presentation to T cells in murine graft-versus-host disease: cross-presentation and the appearance of cross-presentation.
    Wang X; Li H; Matte-Martone C; Cui W; Li N; Tan HS; Roopenian D; Shlomchik WD
    Blood; 2011 Dec; 118(24):6426-37. PubMed ID: 21963602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparan sulfates targeting increases MHC class I- and MHC class II-restricted antigen presentation and CD8(+) T-cell response.
    Knittel D; Gadzinski A; Hua S; Denizeau J; Savatier A; de la Rochère P; Boulain JC; Amigorena S; Piaggio E; Sedlik C; Léonetti M
    Vaccine; 2016 Jun; 34(27):3093-3101. PubMed ID: 27154391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delivery of exogenous antigen into the major histocompatibility complex class I and class II pathways by electroporation.
    Li Y; Ke Y; Gottlieb PD; Kapp JA
    J Leukoc Biol; 1994 Nov; 56(5):616-24. PubMed ID: 7525819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.